Trial intelligence / Profile preview

Kidney Nourishing Fetal Pill for Endometriosis (vitamin D–mediated Th17/Treg balance)

ChiCTR2300077208Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bushen antai wan in endometriosis (2 arms), sponsored by The First Affiliated Hospital of Heilongjiang University of Chinese Medicine. Primary endpoint: Pelvic cyst size under gynaecological vaginal ultrasound. Started Nov 2023; status: recruiting.

02

Drugs

bushen antai wan
03

Conditions

endometriosis

Beyond the preview

Go deeper on ChiCTR2300077208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300077208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call